Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Search results are limited to 1000 results out of 3510. Try refining your search.

Returning 1000 results: Page 1 of 40


Tier Species Size Attr. GeneSet
Tier I 34 GS269423: GWAS Catalog Data for chronic lymphocytic leukemia in 2,179 European ancestry cases, 6,221 European ancestry controls
Tier I 1964 GS123981: propionaldehyde interacting with Homo sapiens associated genes (MeSH:C005556) in CTD
Tier III 17420 GS400133: Transcriptome of the human dorsolateral prefrontal cortex of people with a history of cocaine use vs control (RNA-seq)
Tier III 26035 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 23331 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier IV 3693 GS408178: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development, log2FC
Tier IV 3693 GS408179: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development, Adj-P value
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 11875 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 11651 GS408190: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 13854 GS408216: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) in human opioid use disorder subjects_qvalue
Tier IV 8709 GS391: RIKEN Cerebellum C57BL/6J Development Series
Tier III 428 GS836: Differential expression in Sey Pax6 mutants and controls. Additive effect of mutation, linear increase in both mutants and Wild-types.
Tier III 675 GS1229: Differential gene expression in post-mortem nucleus accumbens (NAc) from people with chronic heroin use history
Tier II 60 GS35073: Striatum Gene expression correlates of Mean time on rotarod following saline in Females & Males BXD
Tier II 203 GS35504: Neocortex Gene expression correlates of Neurogenesis- BrdU labeled new neurons in Adult Rostral Migratory Stream 1 hr post BrdU in Females BXD
Tier II 172 GS36157: Hippocampus Gene expression correlates of Locomotor response of 10 mg/kg MDMA injected on Day 2 in Females BXD
Tier II 590 GS84314: METH responses for body temperature (Published QTL, Chr 19)
Tier II 734 GS84315: METH responses for body temperature (Published QTL, Chr 19)
Tier II 633 GS84316: alcohol preference locus (Published QTL, Chr 19)
Tier II 633 GS84317: alcohol preference locus (Published QTL, Chr 19)
Tier I 4701 GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
Tier I 4701 GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
Tier I 2656 GS121120: entinostat interacting with Homo sapiens associated genes (MeSH:C118739) in CTD